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Background: Prior calculations of the burden of disease from toxic exposures have not included
estimates of the burden from toxic waste sites due to the absence of exposure data.
Objective: We developed a disability-adjusted life year (DALY)-based estimate of the disease
burden attributable to toxic waste sites. We focused on three low- and middle-income countries
(LMICs): India, Indonesia, and the Philippines.
Methods: Sites were identified through the Blacksmith Institute’s Toxic Sites Identification
Program, a global effort to identify waste sites in LMICs. At least one of eight toxic chemicals was
sampled in environmental media at each site, and the population at risk estimated. By combining
estimates of disease incidence from these exposures with population data, we calculated the DALYs
attributable to exposures at each site.
Results: We estimated that in 2010, 8,629,750 persons were at risk of exposure to industrial pollutants at 373 toxic waste sites in the three countries, and that these exposures resulted in 828,722
DALYs, with a range of 814,934–1,557,121 DALYs, depending on the weighting factor used. This
disease burden is comparable to estimated burdens for outdoor air pollution (1,448,612 DALYs)
and malaria (725,000 DALYs) in these countries. Lead and hexavalent chromium collectively
accounted for 99.2% of the total DALYs for the chemicals evaluated.
Conclusions: Toxic waste sites are responsible for a significant burden of disease in LMICs.
Although some factors, such as unidentified and unscreened sites, may cause our estimate to be an
underestimate of the actual burden of disease, other factors, such as extrapolation of environmental
sampling to the entire exposed population, may result in an overestimate of the burden of disease
attributable to these sites. Toxic waste sites are a major, and heretofore underrecognized, global
health problem.
Key words: Asia, burden of disease, chemical exposure, disability-adjusted life year, toxic waste sites.
Environ Health Perspect 121:791–796 (2013). http://dx.doi.org/10.1289/ehp.1206127 [Online
4 May 2013]

Toxic waste sites threaten the environment
and human health in countries around the
world. In developing countries these sites—
and their risks to human health—have not
been optimally assessed (Yáñez et al. 2002).
Quantification of the burden of disease from
toxic waste sites can assist public health planning and remediation efforts by complementing traditional waste site investigations and by
framing these toxic exposures in the context of
other exposures. Burden of disease estimates
are typically expressed in d isability-adjusted
life years (DALYs). The DALY metric
accounts for both the morbidity and mortality that result from a disease, injury, or health
state (Prüss-Üstün et al. 2003).
Previous calculations of the burden of disease from toxic exposures have not included
estimates from toxic waste sites because of
an absence of data on exposures and health
impacts. In 2004, Fewtrell et al. (2004) estimated that lead causes nearly 1% of the global
burden of disease. Then in 2011, Prüss-Üstün
et al. (2011) calculated that exposure to a variety of chemicals, including lead, secondhand
smoke, and asbestos, accounts for 5.7% of
total global DALYs and 8.3% of total global
Environmental Health Perspectives •
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deaths. However, because of insufficient data,
neither of these studies included estimates for
disease and death attributable to exposures
from toxic waste sites.
We aimed to develop a DALY-based
estimate of the burden of disease and death
attributable to toxic waste sites in India,
Indonesia, and the Philippines. To our
knowledge, no systematic evaluation of
toxic waste sites in low- and middle-income
countries (LMICs) had previously been performed. The paucity of data has precluded
calculation of the burden of disease resulting from exposures at these sites. Through
this effort we hope to ultimately calculate the
contribution of toxic waste sites to the global
burden of disease.

Methods
Site identification. In this study, we utilized
data collected through Blacksmith Institute’s
Toxic Sites Identification Program (TSIP),
an effort to identify and screen contaminated
sites in LMICs (Blacksmith Institute 2013).
The TSIP, which is implemented jointly with
the United Nations Industrial Development
Organization, identifies point-source pollution
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from industrial sites that present a public
health risk. A particular focus is placed on
abandoned (legacy) sites, such as former tanneries, as well as small-scale artisanal sources,
such as lead battery recycling and artisanal gold
mining. Although other sources of contamination, such as large-scale mining, may also be
included and screened, the majority of sites
come from these two categories (i.e., legacy
sites and artisanal sources). The TSIP excludes
nonpoint sources, such as ambient urban air
pollution, and non-chemical contamination,
such as sewage-contaminated water. Ericson
et al. (2012) described the types of sites identified in the TSIP.
The Blacksmith Institute developed
an evaluation instrument, the Initial Site
Screening (ISS), for rapid data collection and
assessment of these sites (Blacksmith Institute
2013). The ISS is a modified and simplified
version of the U.S. Environmental Protection
Agency’s (EPA) Hazard Ranking System,
used to prioritize and rank toxic waste sites
in the U.S. EPA’s Superfund program (U.S.
EPA 2012b). The ISS includes information
on the concentration of the key toxic chemical, the primary environmental medium of
the exposure pathway, and the size of the
population at risk.
To undertake the TSIP, the Blacksmith
Institute contracted and trained approximately 150 site investigators. These investigators identified and visited sites, collected
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environmental samples, took photographs and
GPS coordinates, interviewed stakeholders,
and categorized the potential contaminated
environmental media. After being educated on
the project and assured that participation in
the interview process was voluntary, the stakeholders agreed to participate; written informed
consent was not obtained. The investigators
determined the dominant pollutant for each
site based in part on prior testing or historical
use of a site, then took samples to measure
levels of the pollutant, typically in only one
environmental medium. For sites where only
total chromium was reported, the speciation
coefficient of 0.6 was used to estimate hexa
valent chromium (Avudainayagam et al. 2003;
Kumar and Riyazuddin 2010). Between 2009
and 2012, investigators completed 1,510 such
screenings in 49 countries. Since the majority
of screenings occurred in 2010, we used 2010
as our baseline year for analysis. We have previously described the ISS protocol and TSIP in
detail (Ericson et al. 2012).
Population at risk of exposure. As part of
the ISS, investigators estimated the population at risk of exposure for each site, indicating the number of persons regularly coming
into contact with the contaminant in the relevant environmental medium. For example,
if water contamination is documented, then
the population at risk includes those individuals who use the water daily for drinking,
food preparation, and other domestic purposes. Investigators used a range of approaches
to obtain this information, including visual
methods, satellite photographs, community
census data, government interviews, and personal knowledge. The age distribution at sites
was not recorded as part of the ISS. Therefore,
we applied age distribution estimates from the
U.S. Census Bureau (2012) for each country to the population around each site within
that country. We divided each site’s estimated
population into 17 age groups based on these
distributions (e.g., 0–4, 5–9, 10–14 years).
The World Health Organization (WHO)
DALY calculator for cardiovascular disease
resulting from adult lead exposure uses 5 age
groups (i.e., 15–29, 30–44, 45–59, 60–69,
70–79 years). In this study, we condensed the

17 age groups into the appropriate 5 groups to
enable our calculations.
Calculating risk per person. We divided
human health effects into cancer and noncancer effects. For carcinogens, we used the U.S.
EPA’s Regional Screening Level Calculator
for Chemical Contaminants to calculate longterm cancer risk per unit toxicant (i.e., cancer probability per milligram per kilogram
soil for agents found in soil or microgram per
liter water for waterborne agents) (U.S. EPA
2012c). For noncancer health effects, reference
doses (RfDs) and concentrations (RfCs) from
the U.S. EPA’s Integrated Risk Information
System (IRIS) database were applied to the
exposure pathways and contamination levels
at each site (U.S. EPA 2012a). The modeling
assumed a linear dose response and used the
health outcome associated with the RfD or
RfC (e.g., liver toxicity, renal toxicity). A listing of the cancer and noncancer risks per unit
of contaminant, with the exception of lead,
is presented in Table 1. Given the availability of lead-specific modeling tools and dose–
response relationships, we calculated disease
incidence and DALYs from lead separately.
Calculating incidence of disease. For each
chemical, we considered up to three environmental media (soil, water, air) and corresponding routes of exposure (ingestion,
dermal, and/or inhalation). To calculate disease incidence for all chemicals except lead,
we multiplied the risk per person by the level
of the contaminant in the relevant environmental medium. Because linear slope factors
were utilized to calculate incidence, very high
concentrations of contaminants resulted in
correspondingly high estimates of disease incidence. To accommodate this limitation of the
model, we arbitrarily capped incidence for all
diseases at 5%.
For lead, we calculated the incidence of
mild mental retardation and anemia in children and cardiov ascular disease in adults
resulting from lead-induced increases in blood
pressure. We calculated the predicted mean
blood lead levels (BLLs) that would result
from lead exposures at each site by entering the soil and drinking-water lead levels
measured at each site into the U.S. EPA’s

Table 1. Per capita cancer and noncancer human health risks by chemical and media for chemicals
other than lead.
Cancer risk
Chemical (media assessed)
Aldrin (W)
Asbestos (A)
Cadmium (A,S,W)
Chromium VI (A,S,W)
DDT (W)
Lindane (S,W)
Mercury, inorganic (A,S,W)

Per µg/m3 Per mg/kg
in air
in soil
NA
NA
2.30 × 10–1a
NA
1.80 × 10–3
NA
8.40 × 10–2 9.71 × 10–8b
NA
NA
NA
5.08 × 10–6
NA
NA

Noncancer risk
Per µg/L
in water
5.35 × 10–4
NA
NA
2.09 × 10–5
1.07 × 10–5
3.45 × 10–5
NA

Per µg/m3
in air
NA
NA
5.00 × 10–5
NA
NA
NA
5.68 × 10–8

Per mg/kg
in soil
NA
NA
2.67 × 10–8
NA
NA
8.85 × 10–8
8.85 × 10–8

Per µg/L
in water
2.22 × 10–6
NA
1.33 × 10–7
NA
1.33 × 10–7
2.22 × 10–7
2.22 × 10–7

Abbreviations: A, air; DDT, dichlorodiphenyltrichloroethane; NA, not assessed; S, soil; W, water.
aFibers/cubic centimeter. bInhaled airborne dust.

792

volume

Integrated Exposure, Uptake and Biokinetic
(IEUBK) model for lead and Adult Lead
Methodology (ALM) (Caravanos et al. 2012;
U.S. EPA 1994; White et al. 1998). We
calibrated default soil ingestion levels in the
IEUBK model upward from 200 mg/day to
400 mg/day. This approach follows similar
analyses done in Native American populations
(400 mg/day), as well as in indigenous populations in Micronesia (500 mg/day), and is
above the “upper bound” level (200 mg/day)
used by the U.S. EPA (Harris and Harper
2004; Sun and Meinhold 1997; U.S. EPA
2011). Then we calculated the incidence of
mild mental retardation and cardiovascular
outcomes that would result from such BLLs,
using spreadsheets developed by the WHO
(2013). We also assumed that 20% of children with BLLs > 70 µg/dL develop anemia
(Fewtrell et al. 2003).
Calculating years lived with disability (YLDs) and years of life lost (YLLs). The
DALY metric is the sum of two components:
YLD, which represents disease-related morbidity, and YLL, which represents the premature mortality from the disease. We calculated
YLD and YLL for exposure to each contaminant through each relevant environmental
medium. YLD is the product of the estimated
years lived with a given disability multiplied
by its specific disability weight (DW). The
DW is a value from zero to one, depending
on the severity of each disease, with zero representing ideal health and one representing
death. For example, periodontal disease has a
DW of 0.001, whereas a first-time stroke has a
DW of 0.920 (WHO 2008).
For each chemical, we assigned the relevant type of cancer, noncancer health effect,
and corresponding DW (Table 2) (U.S.
EPA 2012a; WHO 2008). If the chemical’s
health effect did not align with a disease in
the WHO DW database, then we selected
the most appropriate disease and DW on
the basis of the target organ, duration of disease, and severity of disease. In the case of
noncarcinogenic effects, the total number of
years of life remaining at onset was multiplied
by the appropriate DW to determine YLD
(Prüss-Üstün et al. 2003). We chose to apply
the exposure for the remainder of an individual’s life expectancy given that most LMICs
do not have a systemic program to identify
and remediate these sites. For carcinogens, we
applied a DW and duration to each cancer
stage: diagnosis (cancer-specific DW; 3 years);
metastasis (DW 0.75; 1 year); and terminal
(DW 0.81; 1 year) (WHO 2008). YLLs were
calculated only for carcinogens. We used cancer incidence and survival data to calculate
the resulting number of deaths (Ferlay et al.
2010; Sankaranarayanan et al. 2010). All cancers were assumed to last 5 years, before either
going into remission or resulting in death.
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For lead, we utilized the environmentally
attributable fraction approach in determining
the contribution of lead exposure to the burden of cardiovascular disease (ischemic heart
disease, cerebrovascular disease, hypertensive
disease, and other cardiac disease) (Fewtrell
et al. 2003). The WHO has calculated the fraction of cardiovascular disease attributable to
lead exposure based on BLL. By entering the
predicted BLL and total cardiovascular disease
DALYs for each country into a WHO spreadsheet, we calculated the DALYs attributable to
cardiovascular disease from lead exposure at
toxic waste sites in each of the three countries.
In addition, for children with BLLs > 10 µg/dL
who did not have mental retardation, we
applied the DW for developmental disability
from protein–energy malnutrition (0.024) as
a proxy DW for lifelong disability from IQ
loss in the absence of mental retardation. Prior
research suggests that the loss of IQ points may
impact cardiovascular and all-cause mortality,
resulting in increased morbidity and mortality
(Batty et al. 2010; Lager et al. 2009).
We then applied weighting factors to
the resulting YLD and YLL for each chemical, including a discount rate to account for
inherent inaccuracies when predicting future
events, and age weights to reflect the relative
societal value of different age groups (Mathers
et al. 2006). The notation DALYs(r,K) signifies the discount rate (r) and age weight (K)
used. Our primary results are expressed as
DALYs(3,1), which include a 3% discount rate
and the full age weight. We also calculated
DALYs(3,0) with the 3% discount rate only,
and DALYs(0,0) without any weighting to provide a range of estimates (Mathers et al. 2006).
For example, the drinking water at one
site in India had an aldrin level of 0.063
ppb. The oral RfD for aldrin for liver toxicity is 3.0 × 10–5 mg/kg/day, which converts
to a risk of 8.57 × 10–10 per microgram per
liter of drinking water (U.S. EPA 2012a,
2012c). The DW for advanced hepatic disease
is 0.104. Assuming the 4,000 persons potentially exposed consume 2 L of drinking water
each day, we calculated 1.62 DALYs(3,0), 1.64
DALYs(3,1), and 2.02 DALYs(0,0) resulting from
exposure to aldrin in drinking water at this site.
Sensitivity analysis. In addition to calculating DALYs with varying rates and weights,
we also altered inputs into our model to conduct a sensitivity analysis. We varied the total
population at risk by 25%, changed the disease
incidence cap from the default value of 5% to
2.5% or 7.5%, and removed the additional
DW for lead-induced IQ (intelligence quotient) losses that did not result in mild mental
retardation. For a remediation scenario, we also
assumed that remediation had reduced all pollutants to concentrations below international
standards (Blacksmith Institute 2011). By subtracting the resulting DALYs from our primary
Environmental Health Perspectives •
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estimate, we quantified the potential impact of
remediating these sites.
We also estimated that an additional
5,000 unscreened sites exist in these countries,
and that these sites present similar conditions
as the screened sites. The TSIP prioritized
screenings in part by the scale of the problem,
measured in population at risk. Thus, these
5,000 sites are unlikely to have comparably
large populations. We therefore assumed that
the population at risk for each of these additional sites was the median of the population
at risk of screened sites, which is lower than
the mean population for screened sites. By
contrast, the DALY per person estimates for
the 5,000 unscreened sites are unlikely to be
lower than those identified at the screened
sites. Sites were not prioritized for screening

based on the level of the contaminant in the
pathway. Therefore, we applied the average
DALY per person for the screened sites to the
population at the unscreened sites.

Results
Sites evaluated. Blacksmith Institute–trained
investigators screened 498 sites in India,
Indonesia, and the Philippines, with an
estimated population at risk of exposure of
approximately 12 million. Of the 23 separate chemicals documented at these sites,
8 occurred at more than one site and had
established dose–response relationships correlating exposure with specific outcomes. We
included in the analysis only the 373 sites
containing 1 of these 8 chemicals. Figure 1
displays the geographical distribution of the

Table 2. Cancer and noncancer health effects and DWs of chemicals found at waste sites.
Chemical
Aldrin (W)
Asbestos (A)
Cadmium (A)
Cadmium (W,S)
Chromium VI (A,W,S)
DDT (W)
Lead (A,W,S)

Cancer site
(classification)a
Liver (probable)
Lung (confirmed)
Lung (probable)
NA
Lung (confirmed)
Liver (probable)
NA

Lindane (W,S)
Mercury, inorganic (W,S)

Liver (possible)
NA

Cancer-specific
DWb
0.20
0.15
0.15
NA
0.15
0.20
NA

Health effect
(noncancer)
Liver toxicity
NA
NA
Renal toxicity
NA
Liver toxicity
Mild mental retardation
Decrement in IQ
Cardiovascular disease
Anemia
Liver toxicity
Renal toxicity

0.20
NA

DW
(noncancer)
0.104c
NA
NA
0.091d
NA
0.104c
0.361
0.024e
NAf
0.024
0.104c
0.091d

Abbreviations: A, air; DDT, dichlorodiphenyltrichloroethane; DW, disability weight; NA, not assessed; S, soil; W, water.
aHuman carcinogenicity classification (U.S. EPA 2012a). bCancer-specific DW was applied for a duration of 3 years,
then a DW of 0.75 was applied for 1 year (metastasis), followed by a DW of 0.81 for 1 year (terminal stage). cAdvanced
hepatic disease. dAcute glomerulonephritis. eDevelopmental disability associated with protein–energy malnutrition.
fDALYs calculated with the environmental attributable fraction approach.
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Figure 1. Locations of 373 toxic waste sites in India, Indonesia, and the Philippines in 2010.
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sites in India (n = 221), Indonesia (n = 73),
and the Philippines (n = 79). The estimated
population at risk of exposure at these 373
sites was 8,629,750 (mean, 23,136, median,
7,000), which is 0.61% of the total population of the three countries. Of the exposed
population, 3,449,592 were < 18 years of age
and 2,184,220 were women of childbearing
age (15–49 years of age). We estimated that an
additional 5,000 unscreened sites exist in the
three countries, with a population of 7,000
persons per site. This additional population
equals 35,000,000, resulting in a total popu
lation of 43,629,750 for the screened and
unscreened sites.
YLD and YLL at screened sites. We estimated 588,112 person-years lived with disease
and 240,610 person-years lost as a result of
chemical exposures in 2010 at the 373 toxic
waste sites (Table 3). According to our estimates, lead was the largest contributor of the
eight chemicals to YLD (523,630 YLD, 89%
of total YLD), and hexavalent chromium
was the largest contributor to YLL (235,483
YLL, 97.9% of total YLL). In Table 3, inhalation of soil and dust is incorporated into the
soil results.
Premature deaths and DALYs at screened
and unscreened sites.We estimated that
828,722 DALYs(3,1) resulted from chemical exposures at the 373 sites in 2010. By
applying the value of 0.10 DALYs (3,1) per
person from the screened sites to the population at the unscreened sites, we estimated that
3,500,000 DALYs(3,1) resulted from exposure
at the unscreened sites. The total estimated

DALYs(3,1) for the screened and unscreened
sites was 4,328,722. We also calculated that
66,747 persons would die prematurely from
cancer, specifically liver and lung cancer, from
exposures at these sites.
Sensitivity analysis. Removal of age
weights yielded 814,934 DALYs (3,0) ,
whereas removal of age weights and the discount rate yielded 1,557,121 DALYs (0,0)
(Table 4). If the actual exposed population
around these sites is 25% less or 25% greater
than our estimate, the resulting DALYs(3,1)
would be 621,541 and 1,035,902, respectively. If the additional DW for lead-induced
IQ loss not resulting in mental retardation
is removed, our overall estimate would be
483,201 DALYs (3,1) . In addition, if disease incidence is capped at 2.5% or 7.5%,
the resulting DALYs(3,1) would be 730,627
and 922,479, respectively. The remediation
scenario yielded 30,317 DALYs(3,1), in contrast with our primary estimate of 828,722
DALYs(3,1). Thus, our estimates suggest that
798,405 DALYs (3,1) could be eliminated
by remediation of these sites to achieve
international standards.

Discussion
We estimated that 8,629,750 persons were
at risk of exposure to one of eight industrial
pollutants at 373 toxic waste sites in three
countries in 2010, resulting in 828,722
DALYs(3,1). This estimate represents a burden
of disease equal to 0.22% of the total estimated DALYs(3,1) from all causes in India,
Indonesia, and the Philippines (WHO

Table 3. YLDs, YLLs, and DALYs by chemical.
Chemical
Aldrin
Asbestos
Cadmium
Chromium VI
DDT
Lead
Lindane
Mercury, inorganic
Total

No. of
sites
5
3
53
128

Estimated
population at risk
133,000
25,000
976,600
3,231,750

4
79
9
92
373

180,000
1,829,900
131,300
2,122,200
8,629,750

YLDs
212
974
15 (S = 1, W = 14)
63,174 (S = 3,582,
W = 59,592)
4
523,630
20 (S = 2, W = 18)
83 (S = 32, W = 51)
588,112

YLLs
812
4,218
0
235,483 (S = 14,467,
W = 221,016)
18
0
79 (S = 6, W = 73)
0
240,610

DALYs
1,024
5,192
15
298,657
22
523,630
99
83
828,722

Abbreviations: DDT, dichlorodiphenyltrichloroethane; S, soil; W, water.

Table 4. Sensitivity analysis estimates.
Scenario
Primary estimate of screened sites
Estimate without age weights
Estimate without age weights or discount rate
Remediation scenario
If actual exposed population is 25% less
If actual exposed population is 25% greater
If additional DW for lead-induced IQ loss not resulting in MMR is removed
If incidence is capped at 2.5%
If incidence is capped at 7.5%
Estimate of unscreened sites
Estimate of screened and unscreened sites

794

Total DALYs
828,722 DALYs(3,1)
814,934 DALYs(3,0)
1,557,121 DALYs(0,0)
30,317 DALYs(3,1)
621,541 DALYs(3,1)
1,035,902 DALYs(3,1)
483,201 DALYs(3,1)
730,627 DALYs(3,1)
922,479 DALYs(3,1)
3,500,000 DALYs(3,1)
4,328,722 DALYs(3,1)
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2008). Alteration of the discount rate and
age weight leads to a range of estimates, from
814,934 DALYs(3,0) to 828,722 DALYs(3,1)
to 1,557,121 DALYs(0,0). Lead and hexavalent chromium account for 99.2% of the
total DALYs estimated for the 8 waste site
chemical exposures evaluated. The additional
DW for lead-induced IQ loss not resulting
in mental retardation accounts for 483,201
DALYs(3,1), which represents approximately
58% of total DALYs(3,1). Inclusion of an estimated number of unscreened sites increased
the estimated population at risk of exposure
to 43,629,750, and the total DALYs(3,1) to
4,328,722. As part of a larger project attempting to calculate the burden of disease of toxic
waste sites in LMICs, the present analysis
indicates that the burden of disease associated
with these sites is substantial and comparable
to well-described diseases and environmental
risk factors. For example, the WHO (2009)
estimated that outdoor air pollution causes
1,448,612 DALYs (3,1) and malaria causes
725,000 DALYs(3,1) in these three countries.
Overall, the present analysis begins to address
the paucity of knowledge regarding health
effects from toxic waste sites in LMICs and
helps frame this issue in the context of other
public health problems.
Given the limited scope of this project
and the understanding that the screened sites
represent only a portion of the total existing sites, we estimated that 5,000 unscreened
sites exist in these three countries. The U.S.
EPA (2004) estimates that there are approximately 294,000 contaminated sites in the
United States alone that require some form
of remediation. India’s population is nearly
four times that of the United States, with
nearly one third of Indian urban residents
living in informal housing settlements, where
unregulated cottage industries can proliferate without zoning or emissions controls
(UN-HABITAT 2007).
Pollutants at toxic waste sites in LMICs
can potentially have profound health effects.
Lead and cadmium adversely affect neuro
development in children, with the in utero
period being the life stage of greatest vulnerability (Ciesielski et al. 2012; Hu et al. 2006).
Children and women of childbearing age constitute 65.3% of the total exposed population in this analysis, highlighting the potential
impact on these vulnerable populations. The
majority of the chemicals are nephrotoxic
or hepatotoxic, and kidney and liver toxicity accounted for the majority of noncancer
health effects. Several are known carcinogens,
including asbestos, cadmium, and chromium.
Previous work has described the difficulty
in identifying which toxic chemicals are being
generated in India via industrial processes,
as well as which ones are being imported
for recycling or disposal (Dutta et al. 2006).
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The actual amount being produced and
imported, and the ultimate fate of many of
these chemicals, is unclear. Misra and Pandey
(2005) discussed the complex requirements
for proper handling of toxic waste to prevent
human exposures and highlight the barriers
to achieving this goal in countries such as
India. Waste is often handled without adequate control mechanisms, such as proper
infrastructure and personal protective equipment, in dense, highly populated areas, exposing not only workers but also residents in the
surrounding communities.
Our estimates highlight the need for remediation of these sites, with a focus on addressing
the key pollutant and dominant environmental medium. High-dose, mass poisonings
periodically come to worldwide attention,
such as recent events in Nigeria and Senegal,
prompting immediate focus and remediation
(Dooyema et al. 2012; Haefliger et al. 2009).
However, exposures from most toxic waste sites
continue unabated. Research has documented
that waste site remediation can be cost-effective
while reducing toxic exposures (Guerriero et al.
2011; Jones et al. 2011).
We must note several limitations of this
analysis. We examined only eight chemicals
and restricted the analysis to only one chemical per site. Persons living near toxic waste
sites are often exposed to multiple chemicals simultaneously (DeRosa et al. 1996;
Hu et al. 2007; Vrijheid 2000). Therefore,
health effects may be increased or decreased
due to the existence of coe xposures and
the potential for synergistic or antagonistic
effects. For example, Claus Henn et al. (2011)
documented a synergistic effect between lead
and manganese in a Mexico City pregnancy
cohort, with the impact of lead on child
neurodevelopment increasing in the group
with higher levels of manganese.
For most of the chemicals, we assigned
only one cancer and one noncancer health
effect. In addition, only a limited number of
diseases have an associated DW, which prevented the inclusion of some health effects.
For example, exposure to hexavalent chromium can cause nasal perforation. However,
there is no DW for nasal perforation, so this
health effect was not included in the analysis.
In several cases there were no specific DWs
that aligned properly with the projected health
effect. Because there is no DW for liver toxicity, for example, we applied the DW for
advanced hepatic disease to those chemicals
known to cause liver toxicity. Although the
major health effect of mercury is the impact
of in utero methylmercury exposure on neuro
development, we were unable to capture
this health effect for various reasons (e.g.,
limited methylmercury samples, no methyl
mercury biomonitoring). An additional source
of uncertainty is the calculation of YLD
Environmental Health Perspectives •
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for cancer, in which each cancer stage was
assigned a different duration and DW.
Limited environmental sampling occurred
at most sites, forcing us to extrapolate results of
several samples to the entire population at risk.
Biomarkers of exposure were not obtained, so
we were unable to confirm completed pathways
of exposure. In the case of lead, we attempted
to offset this limitation by utilizing the U.S.
EPA’s IEUBK model and ALM, which predict
BLLs expected as a consequence of environmental lead exposure. However, these models
may overestimate BLLs when predicted BLLs
are > 30 µg/dL given the uncertainty in the
relationship between environmental lead levels
and BLLs at this level (Hogan et al. 1998). It
is also likely that the actual exposures to the
pollutants vary, with some individuals being
exposed to lower levels. Despite evidence of
prenatal exposure to environmental toxicants
causing adverse health effects (Wigle et al.
2008), our analysis did not account for effects
of prenatal exposures other than lead.
In addition, we assumed that exposures
continued for a lifetime because there are no
established waste site remediation programs in
most LMICs. Although complete elimination
of the toxic exposure may not be feasible for
each site, a reduction in high-level exposure
would decrease our disease burden estimates.
Remediation of all sites such that pollutant
concentrations are below international standards could save 798,405 DALYs(3,1). Finally,
a key limitation of this analysis is its reliance
on slope factors, reference doses, and reference
concentrations, largely based on animal testing. These regulatory values may overestimate
the disease burden given the limitations of
animal testing and the assumptions required
to extrapolate toxicity data from animals to
humans (e.g., applying uncertainty factors).
Acknowledging these limitations, we believe
our analysis presents the best possible estimate
of the burden of disease from these sites given
current data.
Further research should better define the
specific exposures occurring at toxic waste
sites in LMICs by linking environmental
sampling levels, biomarkers of disease, and
health outcomes and focusing on uniquely
vulnerable populations such as women who
are pregnant, children, and the elderly. Such
enhanced surveillance data will help provide
context when comparing toxic waste sites
with more recognized public health threats.
This research should not preclude the immediate remediation of existing sites given the
disease and resulting costs to society that
result from such exposures. Given that the
majority of the DALYs estimated for the eight
chemicals evaluated were due to lead and
chromium exposures, remediation could be
facilitated by selectively targeting lead- and
chromium-contaminated sites.

121 | number 7 | July 2013

Conclusions
This study documents that chemical pollutants from toxic waste sites are a large and
heretofore insufficiently studied public health
problem in the three low- and middle-income
Asian countries that we examined (India,
Indonesia, and the Philippines). Disease and
death caused by toxic chemicals contribute to
the total burden of disease in these countries.
We estimate that > 8 million persons in these
countries suffered disease, disability, or death
from exposures to industrial contaminants in
2010, resulting in 828,722 DALYs(3,1). These
findings underscore the urgent need for toxic
waste sites around the world to be characterized and remediated and for the health of
affected populations to be monitored.
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